CD31/PAS staining elucidated that VM number was greatly increased in pazopanib-resistant ccRCC tumors, along with this was the reduced number of blood vessels (Fig. 1B). The gene discussed is PECAM1; the disease is nonpapillary renal cell carcinoma.